VOLPI, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 21.929
EU - Europa 1.967
AS - Asia 1.155
AF - Africa 65
SA - Sud America 59
OC - Oceania 55
Continente sconosciuto - Info sul continente non disponibili 3
Totale 25.233
Nazione #
US - Stati Uniti d'America 21.855
CN - Cina 396
IT - Italia 373
SG - Singapore 372
UA - Ucraina 325
DE - Germania 298
IE - Irlanda 194
FR - Francia 172
PL - Polonia 126
GB - Regno Unito 112
KR - Corea 102
SE - Svezia 87
RU - Federazione Russa 78
FI - Finlandia 68
IN - India 61
CA - Canada 55
JP - Giappone 40
AU - Australia 37
EG - Egitto 36
BE - Belgio 34
BR - Brasile 32
VN - Vietnam 30
TR - Turchia 28
ID - Indonesia 26
RO - Romania 22
NZ - Nuova Zelanda 18
NL - Olanda 17
NO - Norvegia 16
HK - Hong Kong 15
PK - Pakistan 15
MX - Messico 13
SA - Arabia Saudita 11
ES - Italia 10
PH - Filippine 9
TH - Thailandia 9
ZA - Sudafrica 9
CH - Svizzera 8
IL - Israele 8
MY - Malesia 8
AR - Argentina 6
CL - Cile 6
LR - Liberia 6
CZ - Repubblica Ceca 5
GR - Grecia 5
IR - Iran 5
PE - Perù 5
TW - Taiwan 5
CO - Colombia 4
MA - Marocco 4
VE - Venezuela 4
AT - Austria 3
BG - Bulgaria 3
ET - Etiopia 3
KG - Kirghizistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
DM - Dominica 2
EC - Ecuador 2
EU - Europa 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
NG - Nigeria 2
PR - Porto Rico 2
QA - Qatar 2
UG - Uganda 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BD - Bangladesh 1
DK - Danimarca 1
GT - Guatemala 1
HU - Ungheria 1
IQ - Iraq 1
JM - Giamaica 1
KE - Kenya 1
MD - Moldavia 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 25.233
Città #
Woodbridge 6.560
Wilmington 5.820
Houston 5.655
Ann Arbor 529
Fairfield 432
Chandler 344
Ashburn 328
Singapore 320
Jacksonville 288
Seattle 187
Dublin 184
Dearborn 173
Zhengzhou 165
Cambridge 152
Medford 136
Kraków 122
Beijing 112
Rome 105
Santa Clara 74
Lawrence 66
Redwood City 54
New York 53
Mülheim 45
Shanghai 37
Milan 35
Moscow 28
Menlo Park 27
San Diego 27
Brussels 20
Boardman 19
London 19
Bergen 15
Seongnam 15
Dong Ket 14
Melbourne 14
Norwalk 14
Mumbai 13
Mountain View 12
Ottawa 12
Phoenix 12
University Park 12
Verona 12
Naples 11
Hanoi 10
Hefei 10
Gilgit 9
Izmir 9
Las Vegas 9
Sydney 9
Jakarta 8
Nanjing 8
Palo Alto 8
Pune 8
Guangzhou 7
Napoli 7
Palermo 7
Toronto 7
Auckland 6
Bangkok 6
Bucharest 6
Falls Church 6
Ho Chi Minh City 6
Los Angeles 6
Munich 6
Saint Petersburg 6
Bethesda 5
Birmingham 5
Brisbane 5
Codó 5
Council Bluffs 5
Helsinki 5
Istanbul 5
Kuala Lumpur 5
Renton 5
Rio de Janeiro 5
Riyadh 5
San Mateo 5
Schepdaal 5
Seongbuk-gu 5
Seoul 5
Stockholm 5
Ahmedabad 4
Auburn Hills 4
Bandung 4
Bangalore 4
Boisar 4
Boston 4
Denver 4
Hangzhou 4
Kunming 4
Maturín 4
Montreal 4
Orbassano 4
Pont-Canavese 4
Rochester 4
San Jose 4
Snohomish 4
Taipei 4
Tokyo 4
Turin 4
Totale 22.592
Nome #
Severe complications of herpes zoster 1.312
No evidence of family history as a risk factor for herpes zoster in patients with post-herpetic neuralgia 534
Transmission of human herpesvirus 8: An update 491
Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases 488
Inhibition of homologous recombination by treatment with BVDU (brivudin) or by RAD51 silencing increases chromosomal damage induced by bleomycin in mismatch repair-deficient tumour cells 469
Common fragile sites in colon cancer cell lines: role of mismatch repair, RAD51 and poly(ADP-ribose) polymerase-1 454
Cistite emorragica da Adenovirus in un paziente sottoposto a trapianto di midollo osseo. vol. 39, p. 977-978 438
Prognostic factors of long-term CD4+ count-guided interruption of antiretroviral treatment 436
Clinical and psychosocial correlates of acute pain in herpes zoster 426
Reducing the burden of Herpes Zoster in Italy. 423
Preventing and managing herpes zoster: key actions to foster healthy aging 423
One-year follow-up of patients with long-lasting post-herpetic neuralgia 416
A Systematic analysis of host factors reveals a Med23-interferon-λ regulatory axis against herpes simplex virus type 1 replication 416
Human herpesvirus 8 DNA in serum during seroconversion in allogeneic bone marrow transplant recipients 415
Current management of herpes zoster: The European view 414
Predictors of pain intensity and persistence in a prospective Italian cohort of patients with herpes zoster: relevance of smoking, trauma and antiviral therapy 412
Reducing the burden of Herpes Zoster in Italy. 406
Impact of Underlying Conditions on Zoster-Related Pain and on Quality of Life Following Zoster 405
Clinical and psychosocial correlates of post-herpetic neuralgia 402
Neutralizing antibody response against human cytomegalovirus in allogeneic bone marrow-transplant recipients 401
Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study. 400
5(2-bromovinyl)-2’-deoxyuridine (BVDU), increases the amount of chromatid breaks induced by bleomycin in mismatch repair deficient tumor cells by inhibiting homologous recombination 400
Prevention of Herpes Zoster and its complications: From clinical evidence to real life experience 400
Inflammatory cytokines stimulate vascular smooth muscle cells locomotion and growth by enhancing alpha5beta1 integrin expression and function 393
Cytomegalovirus infection in day care centers in Rome, Italy: viral excretion in children and occupational risk among workers 392
Herpes Zoster and its prevention in Italy. Scientific consensus statement 392
Virus dell’Herpes Simplex. 390
DNA damaging agents can induce celll cycle arrest in different phases of mitosis 385
Role of DNA repair pathways in the control of common fragile sites expression. 385
Interferon-lambda in immunocompetent individuals with a history of recurrent herpes labialis 384
Clinical features and outcome of hospitalized patients with HSV-1 DNA in the lower respiratory tract 383
Frequency of Herpes Zoster recurrence 381
Carotid plaque calcification predicts future cardiovascular events in type 2 diabetes 379
Public awareness and knowledge of herpes labialis 377
Studio sulla relazione esistente tra Nerve growth factor (NGF), infezione da Herpesvirus umano 8 (HHV-8 o KSHV) e patologie HHV-8-correlate. 377
Anticorpi per HHV8 in pazienti con infezione da HIV. 373
Aciclovir, herpes viruses and HIV: a never-ending story 372
Cidofovir on HHV-8 in BCBL-1 cells 368
Un caso di riattivazione contemporanea della infezione da virus Herpes Simplex 1 e 2 in seguito a trapianto di rene. vol. 37, p. 983-984 367
Indagine preliminare sulla storia naturale dell'infezione da Citomegalovirus nell'infanzia 366
Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults 358
Prevalenza di marcatori sierologici dell'infezione da rosolia e da citomegalovirus nel personale femminile degli asili nido. vol. 3, p. 63-65 357
Direct diagnosis of HSV Infections. vol. 5, p. 31-32 355
Indagini sulla reattività anticorpale per Citomegalovirus nel morbo di Sjogren. vol. 37, p. 1014-1015 353
HIV neutralizing antibody titer during structured treatment interruption of highly active antiretroviral therapy 352
Burden of herpes zoster-associated chronic pain in Italian patients aged 50 years and over (2009¿2010): a GP-based prospective cohort study. 345
L'infezione da Citomegalovirus (CMV) in patologia umana. , vol. Numero 0 - Anno 1, p. 38-41 343
DNA repair defects and chromosomal fragile sites expression. 339
null 338
Management of herpes zoster and post-herpetic neuralgia now and in the future 337
Herpes genitale in gravidanza. vol. 23, p. 2-4 336
Role of NGF on cell survival and virus maturation in HHV-8-infected primary effusion lymphoma cells. 335
Infezione da Citomegalovirus di cellule linfomonocitarie. vol. 37, p. 1012-1013 332
null 332
Le infezioni correlate all'assistenza e l'antibioticoresistenza: una sfida globale del XXI secolo 329
Analysis of the cost-effectiveness of varicella vaccine programmes based on an observational survey in the Latium region of Italy 325
Correlates of human herpes virus-8 and herpes simplex virus type 2 infections in Northern Cameroon. 320
Indagini sull'infezione da virus Herpes simplex in casi di vaginite aspecifica in gravidanza. vol. 37, p. 1009-1010 319
Differential effects on mitosis of DNA damaging agents with distinct mechanisms 313
[Ebola Virus Disease (EVD): proposed guideline for hospital triage of suspect and probable cases] 312
Effect of the BH3 mimetic polyphenol (-)-Gossypol (AT-101) on the in vitro and in vivo growth of malignant mesothelioma 312
Epstein-Barr virus and CNS infections 311
La gestione del paziente con Herpes zoster. p. 10-15, ISSN: 0390-0347 279
HEALTHCARE ASSOCIATED INFECTIONSImpact of Diagnosis and Management of Clostridium Difficile Infections (CDI)The Experience of a University Hospital in Rome 213
Herpes zoster in frail elderly patients: prevalence, impact, management, and preventive strategies 139
The potential public health impact of Herpes Zoster vaccination in the 65 years of age cohort in Italy 134
La Terza Missione dell'Università: formazione e salute 55
Malattia da Virus Ebola (MVE): proposta di linea guida per il triage ospedaliero dei casi sospetti e probabili 30
Homologous recombination but not poly(adp-ribose) polymerase-1 is involved in the control of common fragile sites stability 16
Antiviral treatment of varicella in pediatric practice in the Latium region of Italy: results of an observational study 8
Rapid diagnosis and typing of Herpes simplex virus infections by specific monoclonal antibodies | DIAGNOSI RAPIDA E TIPIZZAZIONE VIRALE CON ANTICORPI MONOCLONALI SPECIFICI IN CORSO DI INFEZIONE DA HERPES SIMPLEX 1
Evaluation of the antibody response to EBNA-1 in EBV infections | VALIDITA DELLA RICERCA DEGLI ANTICORPI ANTI EBNA-1 NELLA DIAGNOSTICA DELLE INFEZIONI DA EBV 1
Totale 25.474
Categoria #
all - tutte 44.183
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.183


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.985 0 0 0 575 523 723 545 551 573 517 475 503
2020/20213.982 439 464 436 496 418 455 500 387 112 72 157 46
2021/2022736 22 92 49 49 33 51 37 52 49 61 46 195
2022/20231.071 95 92 24 137 93 222 93 64 92 20 108 31
2023/2024645 59 26 22 39 70 153 31 54 26 38 24 103
2024/2025856 76 424 280 76 0 0 0 0 0 0 0 0
Totale 25.474